JP2023527791A5 - - Google Patents

Info

Publication number
JP2023527791A5
JP2023527791A5 JP2022572323A JP2022572323A JP2023527791A5 JP 2023527791 A5 JP2023527791 A5 JP 2023527791A5 JP 2022572323 A JP2022572323 A JP 2022572323A JP 2022572323 A JP2022572323 A JP 2022572323A JP 2023527791 A5 JP2023527791 A5 JP 2023527791A5
Authority
JP
Japan
Application number
JP2022572323A
Other languages
Japanese (ja)
Other versions
JP2023527791A (ja
JPWO2021242675A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/033848 external-priority patent/WO2021242675A1/en
Publication of JP2023527791A publication Critical patent/JP2023527791A/ja
Publication of JP2023527791A5 publication Critical patent/JP2023527791A5/ja
Publication of JPWO2021242675A5 publication Critical patent/JPWO2021242675A5/ja
Pending legal-status Critical Current

Links

JP2022572323A 2020-05-26 2021-05-24 ウイルス性呼吸器感染症を治療するための方法 Pending JP2023527791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063030214P 2020-05-26 2020-05-26
US63/030,214 2020-05-26
PCT/US2021/033848 WO2021242675A1 (en) 2020-05-26 2021-05-24 Methods for the treatment of viral respiratory infections

Publications (3)

Publication Number Publication Date
JP2023527791A JP2023527791A (ja) 2023-06-30
JP2023527791A5 true JP2023527791A5 (https=) 2024-05-22
JPWO2021242675A5 JPWO2021242675A5 (https=) 2024-05-22

Family

ID=76859702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022572323A Pending JP2023527791A (ja) 2020-05-26 2021-05-24 ウイルス性呼吸器感染症を治療するための方法

Country Status (5)

Country Link
US (1) US20230144927A1 (https=)
EP (1) EP4158025A1 (https=)
JP (1) JP2023527791A (https=)
CN (1) CN116710118A (https=)
WO (1) WO2021242675A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022055817A1 (en) * 2020-09-09 2022-03-17 Gradalis, Inc. Composition formulated into inhalable dosage forms for the treatment of lung|tumors
US20250003010A1 (en) * 2021-11-30 2025-01-02 Gradalis, Inc. Methods for treatment response to cancers
WO2023137404A1 (en) * 2022-01-12 2023-07-20 University Of Virginia Patent Foundation Spike furin cleavage is a sars-cov-2 targeting strategy to break the chain of infection cycle
WO2023198757A1 (en) * 2022-04-14 2023-10-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Alpha-1-antitrypsin for treating paramyxoviridae or orthomyxoviridae infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2252275T3 (https=) 2008-02-13 2018-04-28
US9157084B2 (en) * 2009-12-23 2015-10-13 Gradalis, Inc. Furin-knockdown bi-functional RNA
CN108295087B (zh) * 2009-12-23 2021-01-15 格兰达利斯有限公司 弗林蛋白酶敲减和gm-csf增强的(fang)癌症疫苗

Similar Documents

Publication Publication Date Title
BR112023012656A2 (https=)
BR112021014123A2 (https=)
CL2026000399A1 (es) Conjugados de neodegradador-anticuerpo anti-cd33.
BR112022009896A2 (https=)
JP2023527791A5 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016200A2 (https=)